19. ライソゾーム病 Lysosomal storage disease Clinical trials / Disease details


臨床試験数 : 899 薬物数 : 684 - (DrugBank : 99) / 標的遺伝子数 : 51 - 標的パスウェイ数 : 182

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04787887
(ClinicalTrials.gov)
January 29, 20204/3/2021A Phase I Study to Compare Abcertin and EU-sourced Cerezyme® in Healthy VolunteersA Randomized, Double-blind, 2-treatment, 2-period, Crossover Phase I Study to Compare the PK, Safety and Tolerability of 60 IU/kg of Abcertin, and EU-sourced Cerezyme® in Healthy Volunteers Following a Single Intravenous AdministrationGaucher DiseaseDrug: Abcertin;Drug: EU-sourced CerezymeISU Abxis Co., Ltd.NULLCompleted18 Years45 YearsAll42Phase 1Australia